- Nextleaf (OILS) launches Glacial Gold Vapes and distilled oils through Québec-based medical cannabis platform
- Mendo operates an online portal for medical patients that ships nationwide through www.Mendocannabis.ca
- Québec is the third-largest cannabis market in Canada, representing approximately 15 per cent of Canadian cannabis retail sales in the country
- Nextleaf launched its award-winning, prohibition-era brand Glacial Gold™ in British Columbia last month
- Nextleaf Solutions Ltd. (OILS) is down 1.96 per cent, trading at C$0.25 at close
Nextleaf Solutions Ltd. (OILS) has entered into a supply agreement with Quebec-based licensed producer Medicibis.
Nextleaf will supply its medical platform www.Mendocannabis.ca with Glacial Gold™ branded products.
Mendo operates an online portal for medical patients that ships nationwide through www.Mendocannabis.ca. Glacial Gold™ CBD and THC vapes and distilled oils will be distributed by Mendo to their medical cannabis clients in Quebec and across Canada.
Québec is the third-largest cannabis market in Canada, representing approximately 15 per cent of Canadian cannabis retail sales in the country, and approximately 22 per cent of the Canadian population percent.
Canadian spending on medical cannabis totalled $587 million in 2020. Medical cannabis has become an important component of Canadian healthcare, with $119 million of medical cannabis purchases reimbursed by the Federal Government through Veterans Affairs Canada in 2020. Despite Canada’s progressive cannabis regulation, price is still a major barrier for many medical patients.
Nextleaf leverages its patented high-efficiency ingredient processing technology to improve cannabis oil economics through the low-cost production of cannabis distillate standardized for potency and purity.
“Launching accessibly-priced Glacial Gold™ vapes and distilled oils in Canada’s medical market and in Quebec have been important milestones for Nextleaf. We believe Mendo and their Quebec-based medical platform is positioned to become one of the leading suppliers of medical cannabis to patients and veterans in this country,” said Paul Pedersen, co-founder and CEO of Nextleaf Solutions.
“Our innovative technology enables us to produce high purity ingredients at a low cost per molecule to offer patients quality CBD and THC products,” added Pedersen.
“We are delighted to work with Nextleaf to offer Glacial Gold™ products through our recently expanded national portal, accessible by medical patients Canada-wide,” said Jay Schwartz, Director of Mendo Medical.
“We are excited to feature the seven Glacial Gold™ SKUs that launched last month in British Columbia and to help them launch two new CBD SKUs that we think patients will be eager to experience,” concluded Schwartz.
Nextleaf launched its award-winning, prohibition-era brand Glacial Gold™ in British Columbia last month, receiving national attention for quality products at disruptive price points. Included in the initial launch of Glacial Gold™ were seven total SKUs, consisting of four 1-gram vape SKUs and three distilled oil SKUs.
Glacial Gold™ Distilled CBD 50 Oil, Distilled THC 30 Oil, and Distilled 30:30 Blend feature high-purity distillate in a base of organic coconut MCT oil for a premium consumption experience, without premium pricing.
The initial vape lineup from Glacial Gold™ is offered in two potency levels to match the consumer’s tolerance level or consumption occasion. The Session THC Vape features a full potency THC profile for cannabis enthusiasts who seek a more elevated experience and connection. The Anytime 1:1 Vape is formulated with a balanced THC and CBD profile for consumers looking for a more moderate, go-to vape.
Medicibis is a federally licensed producer of dried cannabis and distributes its products under the brand name ENDO. Medicibis operates out of its 20,000 sq. ft. facility located 15 minutes from downtown Montreal.
Nextleaf is a federally regulated producer of cannabis oil that owns one of the largest portfolios of U.S. patents for the extraction and distillation of cannabinoids.
Nextleaf Solutions Ltd. (OILS) is down 1.96 per cent, trading at C$0.25 at close.
